SCHEMBL10741968

SCHEMBL10741968

C#CCOc1cc([S+](C)[O-])ccc1-c1nc2nccnc2[nH]1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 1/20 0.34
▸ METAP1 P53582 1/20 0.34
▸ PDE2A O00408 1/20 0.33
▸ PDE5A O76074 7/20 0.32
▸ MAOB P27338 2/20 0.32
▸ PGK1 P00558 1/20 0.32
▸ PDE4A P27815 3/20 0.31
▸ PDE4B Q07343 3/20 0.31
▸ PDE4C Q08493 3/20 0.31
▸ PDE4D Q08499 3/20 0.31
▸ AURKA O14965 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ PDE3B Q13370 1/20 0.30
▸ PDE3A Q14432 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10742084 0.89 METAP2 (0.34) METAP2METAP1PDE2APDE5APDE4A
SCHEMBL10741407 0.87 PDE5A (0.44) METAP2METAP1PDE2APDE5APDE4A
SCHEMBL10735148 0.84 PDE2A (0.46) METAP2METAP1PDE2APDE5APDE4A
SCHEMBL10743976 0.83 PDE2A (0.35) METAP2METAP1PDE2APDE5AMAOB
SCHEMBL10741757 0.83 METAP2 (0.34) METAP2METAP1PDE2APDE5APDE4A
SCHEMBL10739010 0.82 PDE2A (0.41) METAP2METAP1PDE2AMAOBCYP1A2
SCHEMBL10743178 0.81 PDE2A (0.52) METAP2METAP1PDE2APDE5AMAOB
SCHEMBL10743165 0.81 METAP2 (0.37) METAP2METAP1PDE2APDE5AMAOB
SCHEMBL10740468 0.81 METAP2 (0.35) METAP2METAP1PDE2APDE5AMAOB
SCHEMBL10739387 0.81 PDE2A (0.41) METAP2METAP1PDE2APDE5AMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4654344-A ALSO AFFECT BLOOD PRESSURE AND MYOCARDIAL CONTRACTIONS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1987-03-31 — — US disclosed
EP-0093951-B1 2-ARYL-TETRAAZAINDENES MERCK PATENT GmbH (DE) 1986-10-29 — — EP disclosed
US-4575505-A Pharmaceutical compositions containing 2-aryltetraazaindenes for treating ulcers or cardiac insufficiency or blood pressure abnormalities MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1986-03-11 — — US disclosed
US-4477454-A INDOTROPIC AGENTS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-10-16 — — US disclosed
EP-0093951-A2 2-Aryl-tetraazaindenes MERCK PATENT GmbH (DE) 1983-11-16 — — EP disclosed
Send feedback